How to Help Your Patients Save Money on Caverject: A Provider's Guide to Savings Programs

Alprostadil injection therapy is highly effective for appropriate patients — but at retail prices exceeding $1,000 for six vials of Caverject 40 mcg, cost is a major barrier to treatment adherence. With the Caverject brand discontinued and the market transitioning to generics in 2025, there is both challenge and opportunity for prescribers to help their patients navigate the new cost landscape. This guide provides actionable strategies for your practice.

Understanding the True Cost of Alprostadil for Your Patients

Cost landscape at a glance in 2026:

Caverject 40 mcg (6 vials) — brand (discontinued): ~$860–$1,058 retail; GoodRx coupons reduced this to ~$884

Caverject Impulse (2 syringes) — brand: ~$288–$308 retail; GoodRx to ~$222, SingleCare to ~$219

Generic alprostadil injection: Now available; pricing is expected to decrease as competition increases — check current GoodRx prices

Compounded Trimix: Often the most affordable per-dose option; varies by compounding pharmacy

Strategy 1: Maximize Insurance Prior Authorization Approval Rates

Most major insurers cover alprostadil products when prior authorization (PA) criteria are met. Successful PA approval is the single most impactful cost-reduction tool for most patients. Common PA criteria across Cigna, BCBS, and Health Net policies include:

Documented diagnosis of erectile dysfunction (ICD-10: N52.x)

Trial and documented failure of at least one oral PDE5 inhibitor, OR contraindication to PDE5 inhibitor use

Post-radical prostatectomy patients: expedited approval pathway available from most plans

Practical PA tips for your practice:

Document specific PDE5 inhibitor names tried and documented adverse effects or inadequate response

Include pertinent medical history (diabetes, prostatectomy, cardiovascular contraindications to PDE5 inhibitors)

Request PA renewal annually to avoid coverage gaps

When switching from Caverject brand to generic alprostadil: submit a new PA request proactively — some insurers require re-authorization for the drug class even when switching within it

Strategy 2: Leverage Generic Alprostadil for Cost Reduction

The most significant cost opportunity in 2026 is the generic alprostadil market that emerged following Pfizer's brand discontinuation in July 2025. Generic medications typically become significantly less expensive as more manufacturers enter the market. Advise patients to:

Ask specifically for generic alprostadil injection rather than brand names

Compare generic prices at multiple pharmacies using GoodRx or SingleCare

Write prescriptions as 'alprostadil injection' (generic) rather than by brand name to ensure generics are dispensed

Strategy 3: Evaluate Compounded Trimix for Cost and Efficacy

For patients where cost is a significant factor, compounded Trimix offers a compelling combination of efficacy and value. Trimix (alprostadil + papaverine + phentolamine) typically:

Costs significantly less per dose than commercial alprostadil products

Requires a smaller injection volume per dose (approximately half the volume of alprostadil monotherapy)

Is associated with less injection-related pain, potentially improving adherence

Note: Trimix is not covered by most commercial insurance plans (it's compounded, not FDA-approved as a specific product). However, the cash price per dose is often lower than the commercial alprostadil copay after PA denial or non-coverage. Partner with a PCAB-accredited compounding pharmacy to ensure product quality.

Strategy 4: Patient Assistance Programs

For uninsured or underinsured patients, patient assistance programs (PAPs) can dramatically reduce medication costs:

Endo Patient Assistance (for Edex): Endo's brand of alprostadil injection may have PAP support — contact Endo directly for current program details

NeedyMeds.org: A comprehensive database of manufacturer PAPs and state programs; search 'alprostadil' for current options

Prescription Hope: Medication access service providing brand-name ED medications through PAPs for a $70/month service fee

Strategy 5: Mail-Order for Insured Patients

For patients with insurance coverage, encourage use of mail-order pharmacy for 90-day supplies. Mail-order typically offers lower copays per unit than retail pharmacy fills, better stock reliability for specialty medications, and reduced hassle from local availability issues. Provide patients with their insurer's mail-order pharmacy information and ensure the PA covers the 90-day supply quantity.

Strategy 6: GoodRx and Discount Cards for Cash-Pay Patients

For patients without insurance or with denied PA, prescription discount cards remain a valuable tool. GoodRx and SingleCare provide significant discounts on both brand and generic alprostadil. Recommend patients check current prices at multiple pharmacies since GoodRx pricing varies by location — and ensure the pharmacy actually stocks the drug before the patient makes a trip. medfinder can help your patients locate pharmacies that both stock the medication and offer discount pricing.

Helping Patients Find Pharmacies That Stock Alprostadil

Cost savings mean nothing if the patient can't find a pharmacy with the medication in stock. Recommend medfinder for providers as a resource patients can use to locate pharmacies near them that can fill their alprostadil injection prescription. medfinder contacts pharmacies on the patient's behalf and texts them results — reducing your office call volume and helping patients get their medication faster.

For a patient-facing version of this information, share our guide: How to save money on Caverject in 2026: coupons, discounts, and patient assistance.